150 related articles for article (PubMed ID: 7571559)
1. Staphylococcus aureus septic arthritis in patients on hemodialysis treatment.
Slaughter S; Dworkin RJ; Gilbert DN; Leggett JE; Jones S; Bryant R; Martin MA
West J Med; 1995 Aug; 163(2):128-32. PubMed ID: 7571559
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
Bloom BS; Fendrick AM; Chernew ME; Patel P
Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
[TBL] [Abstract][Full Text] [Related]
3. Elimination of Staphylococcus aureus in hemodialysis patients.
Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.
Sesso R; Barbosa D; Leme IL; Sader H; Canziani ME; Manfredi S; Draibe S; Pignatari AC
J Am Soc Nephrol; 1998 Jun; 9(6):1085-92. PubMed ID: 9621293
[TBL] [Abstract][Full Text] [Related]
5. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
9. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery.
Yano M; Doki Y; Inoue M; Tsujinaka T; Shiozaki H; Monden M
Surg Today; 2000; 30(1):16-21. PubMed ID: 10648077
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients.
Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L
Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563
[TBL] [Abstract][Full Text] [Related]
12. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
13. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
14. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
15. Screening and treatment for Staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis.
Grothe C; Taminato M; Belasco A; Sesso R; Barbosa D
BMC Nephrol; 2014 Dec; 15():202. PubMed ID: 25519998
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
17. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness.
Boelaert JR; De Baere YA; Geernaert MA; Godard CA; Van Landuyt HW
J Hosp Infect; 1991 Sep; 19 Suppl B():41-6. PubMed ID: 1684192
[TBL] [Abstract][Full Text] [Related]
18. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients.
Nicholson MR; Huesman LA
Am J Infect Control; 2006 Feb; 34(1):44-8. PubMed ID: 16443093
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis.
Nesrallah GE; Cuerden M; Wong JH; Pierratos A
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1047-53. PubMed ID: 20413438
[TBL] [Abstract][Full Text] [Related]
20. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis.
Mylotte JM; Kahler L; Jackson E
Infect Control Hosp Epidemiol; 1999 Nov; 20(11):741-5. PubMed ID: 10580624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
